Editorial comment.
Türkeri
Levent
L
D000230:Adenocarcinoma / Q000097:blood* / Q000188:drug therapy*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood* / Q000187:drug effects*; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D018120:Finasteride; D017430:Prostate-Specific Antigen